On June 23, Patanjali Ayurveda had launched 'Coronil' and 'Swasari'. It had claimed that these two drugs could be used for treating COVID-19 and had successfully treated 100 per cent of the COVID-19 patients it was administered to in clinical trials

Google's June trend search report showed some interesting insights. Post the death of actor Sushant Singh Rajput on June 14, the late actor was the top trending topic across India

Kerala State Drugs and Pharmaceuticals (KSDP) expects to start production of ventilators by July-end after getting approval from Kerala Government and ICMR

Last week, Ramdev's announcement on finding a \"COVID-19 cure\" sparked controversy after questions were raised over the authenticity of its trial process and the company's claim to cure 100 per cent patients who underwent the trial

The PIL filed by advocate Mani Kumar has sought a ban on the drug, accusing the yoga guru of misleading people by launching Coronil as a medicine to cure coronavirus

Share price of Ruchi Soya closed 5% or Rs 68 lower to Rs 1,292 today against previous close of  Rs 1,360 on BSE. The stock opened with a loss of 5% today

Coronil: Patanjali stated that they have shared all the clinical trial data with the AYUSH ministry and that the ministry has categorically agreed that Patanjali Research Foundation has appropriately worked on coronavirus management

Patna administration said that the guidelines were blatantly flouted by the family who went ahead with the wedding despite the groom manifesting COVID-19 symptoms

Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report

Presently tax is levied only on the differential of fair market value (FMV) and actual purchase price, if the house property is acquired at a price lower than the circle rate

\"This programme not only embraces the trend of moving education online but also provides a platform to create skilled and employable women and men in a data-driven world,\" says Prof. Bhaskar Ramamurthi, Director, IIT Madras

On June 23, Baba Ramdev's Patanjali Ayurved had released \"research-based medicine\" Coronil tablet and Swasari vati, claiming 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system

Ruchi Soya share price fell after 22 consecutive sessions of gain. Since May 27, the stock has climbed 198% till date. On May 27, the stock closed at Rs 515 and opened at Rs 1,535 on June 29

According to Shaw, if patients have mild symptoms, they should be given treatment in quarantine centres where their health can be monitored. Only people with complaints of breathlessness and oxygen needs should go to hospitals

Coronavirus update: Maharashtra continues to remain the most-affected state with 1,52,765 coronavirus cases, including 65,844 active cases, 79,815 discharged, and 7,106 deaths

Patanjali's Coronil row: The FIR was filed under various sections of the IPC including Section 420 (Cheating) in Jaipur's Jyoti Nagar Police Station against Ramdev, Balkrishna, scientist Anurag Varshney, National Institute of Medical Science (NIMS) Chairman Balbir Singh Tomar and Director Anurag Tomar

The machine is an automated stand-alone system which uses UV bath technology to disinfect any item within seconds. The disinfector functions with the help of a roller based conveyor carriage that carries any item through the machine chamber

The Rajasthan government has clarified that the drug cannot be not used as a medicine in the state without the permission of the Ministry of AYUSH

Driven by strong rally in recent past, Ruchi Soya has entered into the list of top-100 most valued companies with the market-cap of Rs 45,592 crore

The Haridwar-based company on Tuesday launched \"Coronil\", claiming it can cure COVID-19